IL-17C is similar to IL-17A in promoting the expression of inflammatory cytokines and antibacterial peptides, whereas it is mainly derived from epithelial cells (23), which may explain why more positive samples with IL-17C expression were observed than those with IL-17A expression in breast cancer. This evidence concerns the gene IL17A and breast cancer.